McKesson Corp. Stock
Price
Target price
€442.20
€442.20
0.230%
1.0
0.230%
€564.26
22:26 / Tradegate
WKN: 893953 / Symbol: MCK / Name: McKesson / Stock / Food & Drug Retailing / Large Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
McKesson Corp. Stock
McKesson Corp. gained 0.230% compared to yesterday.
The stock is an absolute favorite of our community with 33 Buy predictions and no Sell predictions.
As a result the target price of 564 € shows a positive potential of 27.54% compared to the current price of 442.2 € for McKesson Corp..
Pros and Cons of McKesson Corp. in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of McKesson Corp. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
McKesson Corp. | 0.230% | 2.194% | -15.788% | 4.511% | 5.773% | 154.002% | 249.203% |
CVS Health Corp. | 3.000% | 8.409% | 10.140% | -13.535% | -20.101% | -21.026% | 2.746% |
Cardinal Health Inc. | 2.150% | 1.985% | -4.035% | 20.217% | 10.733% | 131.176% | 139.856% |
AmerisourceBergen Corp. | -1.310% | 0.175% | -9.107% | 16.330% | 9.045% | 89.245% | 167.004% |
Comments
McKesson Co. (NYSE: MCK) had its price target lowered by analysts at Deutsche Bank Aktiengesellschaft from $623.00 to $579.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MCK provided by MarketBeat
McKesson Co. (NYSE: MCK) had its price target lowered by analysts at Citigroup Inc. from $670.00 to $630.00. They now have a "buy" rating on the stock.
Show more
Ratings data for MCK provided by MarketBeat
McKesson Co. (NYSE: MCK) had its price target lowered by analysts at Leerink Partners from $670.00 to $665.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for MCK provided by MarketBeat